Compare Cigna Corp (CI) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Cigna Corp trades at $273 (market cap $73.56B), while Global X NASDAQ 100 Covered Call ETF trades at $18.14. The key difference: Cigna Corp pays a 2.24% dividend while Global X NASDAQ 100 Covered Call ETF pays none, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Cigna Corp nearer its low. Which is the better fit depends on your goals.
| CI | QYLD | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $311.00 | $18.52 |
52-Week Low | $244.41 | $16.46 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
QYLD trades at $18.14, up 0.33% on the day, with a bullish technical signal from moving averages but bearish oscillators. The ETF offers a high distribution yield, recently around 12%, supported by covered call strategies on the Nasdaq-100. Recent dividends include $0.18 and $0.19 per share, with the latest paid in July 2026. News highlights mixed views, with some analysts upgrading it for income potential while others warn of long-term underperformance versus the Nasdaq-100 index.
Outlook: QYLD appeals for high monthly income in sideways markets, but caps upside during rallies, posing a trade-off between yield and growth. Risks include erosion of net asset value over time and sensitivity to Nasdaq volatility. Investors should weigh income needs against potential capital appreciation limits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
